DICP · 1989 · 11 citations · 9 references
MedicineDermatologyHematologyChemotherapyDermatopathologyHematologic OncologyAdverse Effects Of ChemotherapyChemotherapy In Hematologic MalignanciesCutaneous LymphomaDrug-induced Skin ReactionsHematologic MalignanciesHigh-dose ChemotherapyAutologous Transplant ConditioningChemotherapy Administration In LymphomaChemotherapy-induced Dermatologic ToxicityCyclophosphamide-based TherapyDrug-induced ErythrodermaHypersensitivity Reactions To ChemotherapyLymphoma ChemotherapyMedication-induced Erythema
A 33-year-old woman with stage IIIA non-Hodgkin's lymphoma unresponsive to ten cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) developed a variant of the chemotherapy-associated erythrodysesthesia syndrome following high-dose cyclophosphamide and radiation in preparation for an autologous bone marrow transplant. The patient first complained of a new rash on her fingers and toes on day 6 after her first dose of cyclophosphamide. Unlike the previous case reports in which patients presented with a palmar-plantar erythema, this patient's rash occurred on the dorsal aspects of her hands and feet, and not on her palms and soles. After evaluation by a dermatologist she was diagnosed as having a variant of palmar-plantar erythema induced by cyclophosphamide.
9
High-dose cytosine arabinoside therapy for refractory leukemia
RH Herzig, SN Wolff, HM Lazarus et al. · Blood · 1983 · 370 citations · Full text
Medicine, Oncology, Pharmacology +12
Chemotherapy-Associated Palmar-Plantar Erythrodysesthesia Syndrome
J J Lokich · Annals of Internal Medicine · 1984 · 226 citations
Medicine, Oncology, Pharmacology +16
Erythema and Desquamation After High-Dose Methotrexate
L. Austin Doyle · Annals of Internal Medicine · 1983 · 77 citations